Product Details
1/EA
$ *.**
In StockAdditional Information
| Manufacturer # | 00169-4181-13 |
| Brand | Ozempic® |
| Manufacturer | NOVO NORDISK |
| Application | Treatment of type 2 diabetes mellitus |
| Container Type | Prefilled pen |
| Dosage Form | Injectable solution |
| Generic Drug Name | Semaglutide |
| Ndc Number | 00169418113 |
| Strength | 0.25 mg |
| Type | Subcutaneous injection |
| Volume | 1.5 mL per pen |
Description:
The Ozempic® (semaglutide) 0.25/0.5 mg per 3 mL pen is a once-weekly GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease; its mechanism of action leverages the native GLP-1 function to stimulate insulin secretion and suppress glucagon secretion in a glucose-dependent manner, thereby effectively lowering A1C with a low risk of hypoglycemia.
Frequently Asked Questions (FAQs)
The cost of Ozempic® 0.25/0.5 MG PFP 3 ML is $$0.00
Ozempic® 0.25/0.5 MG PFP 3 ML is manufactured by NOVO NORDISK.
You can purchase Ozempic® 0.25/0.5 MG PFP 3 ML on our website at https://injx.pipelinemedical.com/product/detail/ozempic-brand-name-semaglutide-inj-25mg-1x1-5ml-639206